Studies of the absorption, distribution and utilization of a potential new haematimic (I-I-diethyl alpha-alpha-thiabiscyclopentaddienyl-iron) in normal mice and mice with sex-linked anaemia.
D000747:Anemia, Hypochromic / Q000188:drug therapy* / Q000235:genetics; D000818:Animals; D001682:Biological Availability; D003517:Cyclopentanes / Q000627:therapeutic use; D004912:Erythrocytes / Q000378:metabolism; D004920:Erythropoiesis; D005808:Genes, Recessive; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism; D007477:Ions; D007501:Iron / Q000378:metabolism / Q000627:therapeutic use*; D007504:Iron Radioisotopes; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D051379:Mice; D009929:Organ Size; D009942:Organometallic Compounds / Q000378:metabolism / Q000627:therapeutic use*; D012729:Sex Chromosome Aberrations; D013154:Spleen / Q000033:anatomy & histology / Q000378:metabolism
D003517:Cyclopentanes; D006454:Hemoglobins; D007477:Ions; D007504:Iron Radioisotopes; D009942:Organometallic Compounds; D007505:Iron-Dextran Complex; D007501:Iron